Commercialized Products
Commercial Validation of Our Technology
LIVIUS’s commercialized products represent the real-world validation of our cellular reprogramming platform.
Developed within established regulatory frameworks, these products translate advanced epigenetic science into market-ready applications. Beyond commercialization, they provide practical insights that continuously inform and strengthen our therapeutic research and drug discovery pipeline.
LIVIUS EPI Series – Epigenetic Skincare
The LIVIUS EPI Series is a science-driven skincare line developed from our cellular reprogramming and epigenetic research.
Formulated to support skin function and cellular balance, these products reflect the application of our platform in a regulated consumer setting, serving as an early validation of our core technology.
Products include:
- Cleansing Foam
- Booster Essence
- Skin Lotion
- Intensive Serum
- Moisturizing Emulsion
- Face Mask
Professional & Salon-Use Formulations
Technology in Controlled Environments
LIVIUS also develops professional-use formulations designed for use in clinical and salon settings.
These products enable closer observation of formulation performance and biological response, providing valuable feedback that supports platform optimization and translational research.
Topical Regenerative Formulations
Exploratory Commercial Applications
Select topical formulations explore the application of our reprogramming technology to areas associated with tissue regeneration and cellular turnover.
These products contribute to platform learning while remaining distinct from therapeutic development programs.
